Suppr超能文献

基于组织工程支架构建血管移植物。

Construction of vascular grafts based on tissue-engineered scaffolds.

作者信息

Lang Zhongliang, Chen Tianao, Zhu Shilu, Wu Xizhi, Wu Yongqi, Miao Xiaoping, Wang Qiang, Zhao Liping, Zhu Zhiqiang, Xu Ronald X

机构信息

Department of Plastic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, PR China.

School of Biomedical Engineering, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230026, PR China.

出版信息

Mater Today Bio. 2024 Nov 10;29:101336. doi: 10.1016/j.mtbio.2024.101336. eCollection 2024 Dec.

Abstract

Cardiovascular disease (CVD) ranks among the leading causes of morbidity and mortality globally, primarily due to arterial occlusive disease. Vascular bypass remains the cornerstone of treatment; however, many patients lack suitable autologous vessels (e.g., saphenous vein) for grafting. Tissue-engineered vascular grafts (TEVGs) provide a viable alternative capable of integrating, remodeling, and repairing host vessels, responding to mechanical and biochemical stimuli. Currently, preparation methods for TEVGs are mainly categorized into scaffold-free and scaffold-based approaches. Scaffold-free methods exhibit comparatively weaker mechanical properties and limited research progress, whereas scaffold-based approaches show more promising applications due to their superior mechanical properties and biocompatibility. This review examines current research progress in materials, fabrication processes, functionalized modifications, cell implantation, and animal and clinical experiments for scaffold-based preparation of TEVGs. By exploring current challenges and future perspectives in this field, we expect to provide new insights into TEVGs development and expedite their clinical applications.

摘要

心血管疾病(CVD)是全球发病和死亡的主要原因之一,主要归因于动脉闭塞性疾病。血管搭桥术仍然是治疗的基石;然而,许多患者缺乏适合移植的自体血管(如大隐静脉)。组织工程血管移植物(TEVG)提供了一种可行的替代方案,能够整合、重塑和修复宿主血管,对机械和生化刺激做出反应。目前,TEVG的制备方法主要分为无支架和有支架两种途径。无支架方法的机械性能相对较弱,研究进展有限,而有支架方法由于其优越的机械性能和生物相容性,显示出更有前景的应用。本文综述了基于支架制备TEVG在材料、制造工艺、功能化修饰、细胞植入以及动物和临床试验方面的研究进展。通过探讨该领域当前的挑战和未来前景,我们期望为TEVG的发展提供新的见解,并加速其临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/97b8d3a92c5c/ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验